Back to Authors

Doshi, Krupa B

https://orcid.org/0000-0002-1065-8282

Mayo Clinic

Mayo Clinic in Arizona

Citations 3

Normocalcemic primary hyperparathyroidism: an update on diagnostic and management challenges
Doshi, Krupa , Chandran, Manju , Doshi, Krupa B

Current Opinion in Endocrinology, Diabetes & Obesity | May 27, 2026 | Volume: 33 | Issue: 4 | Pages: 131-136

10.1097/med.0000000000000965 Get It

Purpose of review Normocalcemic primary hyperparathyroidism (NPHPT) is defined by persistently elevated parathyroid hormone (PTH) levels in the presence of normal total and ionized serum calcium after excluding secondary causes of PTH elevation. Increasing use of biochemical screening has led to growing recognition of this phenotype, yet uncertainties remain regarding its natural history, diagnostic criteria, and optimal management. Recent findings NPHPT shares several clinical features with hypercalcemic primary hyperparathyroidism (HPHPT). Substantial rates of osteoporosis, fragility fractures, and nephrolithiasis are reported. Diagnosis requires repeated biochemical measurements, confirmation of normal ionized calcium, and rigorous exclusion of secondary causes such as vitamin D insufficiency, chronic kidney disease, malabsorption, and medication effects. Preoperative localization may also be more difficult than in HPHPT due to smaller adenomas and higher prevalence of multigland disease. Summary Parathyroidectomy appears safe and effective in selected individuals. However, NPHPT may carry a greater risk of recurrence than HPHPT. Improvements in bone mineral density (BMD) and quality of life (QOL) have been reported after surgery, although renal outcomes remain less certain. This review summarizes current evidence on the epidemiology, diagnosis, clinical manifestations, and management of NPHPT and highlights key areas requiring further study.
Calloused, Hyperpigmented Fingertips
Doshi, Krupa B , Doshi, Krupa

New England Journal of Medicine | February 4, 2023 | Volume: 388 | Issue: 6 | Pages: No page available

10.1056/nejmicm2036309 Get It

Positive HLA‐B27 and sacroiliitis is not always spondyloarthritis
Aslam, Fawad , Chivers, F. Spencer, Doshi, Krupa , Chang‐Miller, April, Chivers, Frederick Spencer, Doshi, Krupa B , Aslam, Fawad

International Journal of Rheumatic Diseases | November 11, 2019 | Volume: 22 | Issue: 12 | Pages: 2213-2217

10.1111/1756-185x.13738 Get It

AbstractA 36‐year‐old man was treated for several years with multiple agents for ankylosing spondylitis based on positive human leukocyte antigen‐B27 and sacroiliitis. He was also diagnosed with osteoporosis and hypophosphatemia. Over these years, from being an avid runner, he became dependent on a walker for ambulation. The lack of treatment response and the low phosphorus were clues that eventually led to a diagnosis of tumor‐induced osteomalacia. This case discusses the importance of not solely relying on genetic markers and sacroiliitis for diagnosing ankylosing spondylitis as other conditions can cause similar presentations.